Addressing Drop Adherence

Show Description +

I. Paul Singh, MD, describes the use of iStent Infinite (Glaukos) and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to help reduce the drop burden for this patient.

Financial disclosure: Consultant (Glaukos)

Posted: 1/02/2024

Keywords:

iStent

•

Glaucoma Drop Therapy

•

Dextenza

Up Next

FLACS With Toric and iStent inject

Blake Williamson, MD, MPH, MS

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Eric Rosenberg, MD

Cataract Surgery Combined with Canaloplasty

Mahmoud A. Khaimi, MD

Needle Viscocanalostomy

Eslam Ramadan, MD

Ahmed M4 Placement

Nathan Radcliffe MD

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Ian Conner, MD

Supra-Tenons Baerveldt Glaucoma Drainage Device

George Tanaka, MD

iStent Trabecular Microbypass Implantation Technique

Ike K. Ahmed MD

Trabectome 180

Constance Okeke, MD, MSCE

New Directions for GT

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

Addressing Drop Adherence

I. Paul Singh, MD

Posted: 1/02/2024

Keywords:

iStent

•

Glaucoma Drop Therapy

•

Dextenza

Please log in to leave a comment.

More in Glaucoma

Academy IRIS® Registry Data Outcomes on Gel Stent Use

Arsham Sheybani, MD

Angle-Based MIGS for a Patient With Severe Glaucoma

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

When a Minimally Invasive Procedure Fails

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Rachel G. Simpson, MD

Innovations in Glaucoma: The FYSX OPAP Device

I. Paul Singh, MD; and John P. Berdahl, MD